Literature DB >> 27905851

Peptide Receptor Radionuclide Therapy for Sarcoidosis.

Constantin Lapa1, Götz Ulrich Grigoleit1, Heribert Hänscheid1, Erdwine Klinker1, Pius Jung1, Ken Herrmann1, Andreas Schirbel1, Markus Böck1, Andreas K Buck1, Theo Pelzer1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27905851     DOI： 10.1164/rccm.201603-0579LE

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  3 in total

Review 1.  The theranostic promise for Neuroendocrine Tumors in the late 2010s - Where do we stand, where do we go?

Authors:  Rudolf A Werner; Alexander Weich; Malte Kircher; Lilja B Solnes; Mehrbod S Javadi; Takahiro Higuchi; Andreas K Buck; Martin G Pomper; Steven P Rowe; Constantin Lapa
Journal:  Theranostics       Date:  2018-11-29       Impact factor: 11.556

2.  Sandostatin therapy in patients with chronic sarcoidosis.

Authors:  M C Timmermans Wilhelmina; A M van Laar Jan; A S H Dalm Virgil; L R Kam Boen; van Hagen P Martin; L A van Daele Paul
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2020-03-09       Impact factor: 0.670

3.  Peptide receptor radionuclide therapy as a new tool in treatment-refractory sarcoidosis - initial experience in two patients.

Authors:  Constantin Lapa; Malte Kircher; Heribert Hänscheid; Andreas Schirbel; Götz Ulrich Grigoleit; Erdwine Klinker; Markus Böck; Samuel Samnick; Theo Pelzer; Andreas K Buck
Journal:  Theranostics       Date:  2018-01-01       Impact factor: 11.556
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.